Disclaimer: I own shares of PACB at the time of publishing this analysis.
The below analysis is not a trading or investment recommendation & is only for learning purpose.
1.PACB has been in a major downtrend like most other small caps & biotech stocks.
2.The stock is way below the 200DMA which sits around $25.
3.The spread between the 20DMA & 200DMA is also very...